21 CFR § 862.3150 Clinical Chemistry and Clinical Toxicology Devices

§ 862.3150 Barbiturate test system.

Current through Sep 8, 2026 · Read all of Part 862

⚠ 2 pending changes to Part 862

(a) Identification. A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.

(b) Classification. Class II (special controls). A barbiturate test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

[52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019; 91 FR 63486, Oct. 6, 2026]

← § 862.3120 Arsenic test system.§ 862.3170 Benzodiazepine test system. →